Bank Of New York Mellon Corp Lava Therapeutics Nv Transaction History

Bank Of New York Mellon Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.28 - $4.4 $5,640 - $10,885	-2,474 Reduced 14.02%	15,173 $45,000
Q3 2021 Nov 12, 2021	SELL	$5.5 - $11.0 $42,025 - $84,051	-7,641 Reduced 30.22%	17,647 $104,000
Q2 2021 Aug 11, 2021	SELL	$10.8 - $16.0 $97,534 - $144,496	-9,031 Reduced 26.31%	25,288 $275,000
Q1 2021 May 13, 2021	BUY	$12.5 - $15.19 $428,987 - $521,305	34,319 New	34,319 $521,000

3.61M

32.9K

500

Ticker LVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,797,700
Market Cap $26.8M
Description
LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.